Fig. 6From: Early vs. late MRD response- and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi ArabiaThe 5-year overall survival (a), event-free survival (b), and cumulative incidence of relapse (c) based on response: rapid early response (RER) vs. slow early response (SER). Patients with SER had significantly (p < 0.05) worse results for all three outcome measures. HR hazard ratioBack to article page